Cerbo, Edna V.
HRN: 24-48-93 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2025
CEFTRIAXONE 1G (VIAL)
10/24/2025
10/31/2025
IV
2g
Q24
TBI
Checking Final Appropriateness